Mouse Anti-RAMP1 Recombinant Antibody (clone JF2) (CAT#: NS-068CN)

Figure 1 The effect of the monoclonal antibodies on the growth of SW-13 cells in vitro.

Monoclonal anti-RAMP-3 antibodies were tested for their ability to induce inhibition of proliferation of SW-13 (adrenocarcinoma cells). The concentration of 1 :50 equates to about 5ng per well final concentration.

Figure 2 A MTT assay assessing the rate of proliferation in the U-87 glioblastoma cell line in the presence of antibody JF2 at varying concentrations (after 8 days of culture).

Figure 3 A MTT assay assessing the rate of proliferation in the MDA-MB-436-GFP breast cancer cell line in the presence of antibody JF2 at varying concentrations (after 8 days of culture).

Figure 4 A MTT assay assessing the rate of proliferation in the PC-3 prostate cancer cell line in the presence of antibody JF2 at a concentration of 10Mg (after 8 days of culture).

Figure 5 An apoptosis assay assessing the levels of caspase-3 a marker in U-87 glioblastoma cancer cell line in the presence of antibody JB3 and JF2.

Figure 6 An apoptosis assay assessing the levels of caspase-3 a marker in a MDA-MB-436-GFP breast cancer cell line in the presence of antibody JB3 and JF2.

Figure 7 The tumour volume of MDA-MB-436-GFP injected into the right flank of CD1 nude mice, treated with JF2 antibody and controls over a period of 6 weeks.